Latest Production And Reserves News

Brookside Energy has locked in Kenai Drilling’s Rig 18 for a two-well program at its SWISH Area of Interest in Oklahoma’s Anadarko Basin, aiming to maintain momentum in its core US operations.

Kaiser Reef Limited (ASX:KAU) delivered 5,534oz of gold across its Henty and Maldon operations in Q1 2026, grew its cash balance to A$45.6 million, and outlined plans to address production shortfalls at Henty while expanding capacity at Maldon.

Brookside Energy has commenced site preparation for a two-well development pad in the SWISH Area of Interest, with drilling set to begin in May 2026 targeting key formations in the Anadarko Basin.

Brookside Energy has reported a modest increase in its total proved plus probable reserves to 12.52 million barrels of oil equivalent, driven by strong performance from its operated wells in Oklahoma’s SWISH play. The company’s proved developed producing reserves also rose by 5%, underscoring steady operational progress.

Kaiser Reef Limited reported a robust December quarter with nearly 7,000 ounces of gold produced at Henty, a 29% increase in gold reserves, and a strengthened cash position of A$43.1 million.

Emerald Resources NL reported solid December quarter gold production from its Okvau Gold Mine and significant resource upgrades at its Dingo Range and Memot projects, underpinning its growth trajectory.

Arafura Rare Earths has raised A$481 million in equity funding and secured key government backing, advancing its Nolans Project towards a final investment decision in 2026.

Central Petroleum has completed its acquisition of strategic interests in the Otway and Cooper Basins, setting the stage for a multi-well exploration campaign starting in the second half of 2026.

Central Petroleum has confirmed its strategic acquisition in the Cooper and Otway Basins is now unconditional, with completion set for 23 January 2026, marking a significant expansion of its asset portfolio.

Integrated Research Limited reported a modest revenue dip and significant profit declines in FY25 as it pivots to a product-led growth strategy focused on AI-powered observability solutions and hybrid pricing models.

Kinetiko Energy has reported record gas flow rates from its Brakfontein test wells, renewed critical exploration rights, and signed a joint venture to develop a pilot LNG plant, marking a significant step towards commercial gas production in South Africa.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.